Overview

We work closely with clients to build customized programs that start by envisioning the precise requirements of each lead antibody. Our team designs a unique discovery and development program – consisting of in vivo, in vitro, and in silico technologies, based on an in-depth understanding of your target and its intended mode of action.

Since 2018, AVS Bio has helped more than 100 life sciences companies launch successful lead antibody programs, including the development of 10 antibodies that entered clinical trials. This includes more than 300 projects ranging from targeted tool generation to comprehensive antibody discovery and development, with end-to-end support from idea to production for preclinical testing. We also completed over 3,250 standalone protein production and purification programs over the past decades. Our clients trust us for our expertise, efficiency, and commitment to turning complex challenges into successful outcomes.